2023
Effect of a Personalized Tobacco Treatment Intervention on Smoking Abstinence in Individuals Eligible for Lung Cancer Screening
Cartmel B, Fucito L, Bold K, Neveu S, Li F, Rojewski A, Gueorguieva R, O'Malley S, Herbst R, Toll B. Effect of a Personalized Tobacco Treatment Intervention on Smoking Abstinence in Individuals Eligible for Lung Cancer Screening. Journal Of Thoracic Oncology 2023, 19: 643-649. PMID: 37977486, PMCID: PMC10999350, DOI: 10.1016/j.jtho.2023.11.012.Peer-Reviewed Original ResearchStandard of careLung cancer screeningCancer screeningQuit ratesGain-framed messagingPack-year smoking historySmoking cessation ratesSmoking quit ratesNumber of cigarettesTobacco treatment interventionsYears of ageCessation/reductionChi-square testSelf-reported numberSmoking historyStandard careCessation ratesRandomized trialsTobacco treatmentTobacco cessationBiomarker feedbackLung cancerSmoking abstinencePost randomizationSmoking behavior
2020
An integrated behavioural intervention combined with varenicline for heavy-drinking smokers: a randomized pilot study.
Fucito LM, Wu R, O'Malley SS, Hanrahan TH, Ikomi JT, Muvvala S, Carroll KM, Gueorguieva R. An integrated behavioural intervention combined with varenicline for heavy-drinking smokers: a randomized pilot study. The Journal Of Smoking Cessation 2020, 15: 119-127. PMID: 33312238, PMCID: PMC7731353, DOI: 10.1017/jsc.2020.13.Peer-Reviewed Original ResearchFeasibility/acceptabilityHeavy drinking smokersAlcohol counsellingHeavy drinkingBehavioral interventionsPilot studyOpen-label vareniclineRandomized pilot studySignificant health burdenComputer-generated tableTobacco pharmacotherapyHealth burdenQuit ratesPilot trialResearch clinicDrinking reductionsVareniclineBehavioural counsellingAlcohol treatmentCombined smokingMedium effect sizeSmokingSmokersCounsellingDrinking
2017
Personalized Intervention Program: Tobacco Treatment for Patients at Risk for Lung Cancer
Bold KW, Toll BA, Cartmel B, Ford BB, Rojewski AM, Gueorguieva R, O'Malley SS, Fucito LM. Personalized Intervention Program: Tobacco Treatment for Patients at Risk for Lung Cancer. The Journal Of Smoking Cessation 2017, 13: 244-247. PMID: 32431757, PMCID: PMC7236885, DOI: 10.1017/jsc.2017.24.Peer-Reviewed Original ResearchLung cancerTobacco treatmentBiomarker feedbackCessation/reductionStandard careExpired carbon monoxideLung cancer screeningPoint prevalence abstinenceCurrent smokersLung functionPrimary outcomeCessation ratesCessation therapyCancer screeningQuit ratesSkin carotenoidsPlasma bilirubinGain-framed messagesNovel biomarkersPatientsNovel interventionsCancerPast weekSequential interventionsGain-framed messaging
2014
Smokers’ Treatment Expectancies Predict Smoking Cessation Success
Fucito LM, Toll BA, Roos CR, King AC. Smokers’ Treatment Expectancies Predict Smoking Cessation Success. The Journal Of Smoking Cessation 2014, 11: 143-149. PMID: 27594921, PMCID: PMC5006744, DOI: 10.1017/jsc.2014.17.Peer-Reviewed Original ResearchTreatment expectanciesQuit ratesPlacebo-controlled trialSmoking cessation successBetter treatment responseSmoking cessation aidSmoking cessation outcomesHigher quit ratesLower quit ratesNaltrexone groupPlacebo groupQuit dateCessation treatmentNicotine patchCessation aidCessation successCigarette smokersParticular medicationCessation outcomesTreatment responseBehavioral counselingMedication experienceTreatment assignmentFirst monthSmokers